By John Kruzel WASHINGTON (Reuters) -The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to revive patents on its cholesterol-lowering drug Repatha in a legal clash with French rival[...]
Read more
Health
Explainer-The latest on tax credit rules in Biden’s climate and drugs bill
By Jarrett Renshaw and Philip Blenkinsop (Reuters) – U.S. President Joe Biden’s Inflation Reduction Act (IRA), cheered by some Democrats and the White House as a milestone in the fight aga[...]
Read more
Walgreens reaches $230 million opioid settlement with San Francisco
By Jonathan Stempel (Reuters) -San Francisco said on Wednesday it reached a $230 million settlement with Walgreens Boots Alliance Inc over its role in the city’s opioid epidemic. The settlement[...]
Read more
Theranos founder Elizabeth Holmes to report to prison in two weeks
By Jody Godoy (Reuters) – Theranos founder Elizabeth Holmes will begin serving her prison sentence on May 30 for defrauding investors in the failed blood-testing startup once valued at $9 billio[...]
Read more
Analysis-Amgen’s antitrust woes spur wider pharmaceutical deal fears
By David Carnevali NEW YORK (Reuters) – Investors are scrambling to assess the fallout of a U.S. regulatory challenge against Amgen Inc’s proposed $27.8 billion acquisition of Horizon Ther[...]
Read more
Theranos founder Holmes loses bid to stay out of prison, hit with huge restitution bill
By Jody Godoy (Reuters) -Theranos founder Elizabeth Holmes and former CEO Ramesh “Sunny” Balwani were on Tuesday ordered to pay $452 million to victims of the blood-testing startup’s[...]
Read more
Norfolk Southern bondholders sue over safety disclosures preceding Ohio derailment
By Jonathan Stempel NEW YORK (Reuters) – Norfolk Southern Corp was sued on Tuesday by bondholders who said they lost hundreds of millions of dollars because the railroad concealed safety risks p[...]
Read more
US FTC sues to block Amgen’s $27.8 billion deal for Horizon Therapeutics
By Diane Bartz and Leroy Leo WASHINGTON (Reuters) -The U.S. Federal Trade Commission said on Tuesday it has filed a lawsuit to stop Amgen Inc’s $27.8 billion acquisition of Horizon Therapeutics[...]
Read more
J&J’s proposed talc settlement would pay $400 million to US state AGs
By Dietrich Knauth NEW YORK (Reuters) – Johnson & Johnson has set aside $400 million to resolve U.S. state consumer protection actions as part of its broader $8.9 billion effort to settle cl[...]
Read more